Document is current

Any future updates will be listed below

Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells

Crossref DOI link: https://doi.org/10.1038/s41571-025-01036-8

Published Online: 2025-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark